-
公开(公告)号:WO2007136940A2
公开(公告)日:2007-11-29
申请号:PCT/US2007/066359
申请日:2007-04-11
申请人: SMITHKLINE BEECHAM CORPORATION , DARCY, Michael, Gerard , KNIGHT, Steven, David , ADAMS, Nicholas, D. , SCHMIDT, Stanley, J.
IPC分类号: A61K31/4709
CPC分类号: C07D417/14
摘要: Invented is a method of inhibiting the activity/function of PI3 kinases using thiazolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiazolidinedione derivatives.
摘要翻译: 本发明是使用噻唑烷二酮衍生物抑制PI3激酶的活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用噻唑烷二酮衍生物的移植排斥和肺损伤。
-
公开(公告)号:WO2008157191A3
公开(公告)日:2008-12-24
申请号:PCT/US2008/066619
申请日:2008-06-12
申请人: SMITHKLINE BEECHAM CORPORATION , ADAMS, Nicholas, D. , BURGESS, Joelle, Lorraine , DARCY, Michael, Gerard , KNIGHT, Steven, David , NEWLANDER, Kenneth, Allen , RIDGERS, Lance, H. , SCHMIDT, Stanley, J.
发明人: ADAMS, Nicholas, D. , BURGESS, Joelle, Lorraine , DARCY, Michael, Gerard , KNIGHT, Steven, David , NEWLANDER, Kenneth, Allen , RIDGERS, Lance, H. , SCHMIDT, Stanley, J.
IPC分类号: A01N43/54 , A61K31/517
摘要: Invented is a method of inhibiting the activity/function of P13 kinases using quinazoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinazoline derivatives.
-
公开(公告)号:WO2007136940A3
公开(公告)日:2008-12-04
申请号:PCT/US2007066359
申请日:2007-04-11
申请人: SMITHKLINE BEECHAM CORP , DARCY MICHAEL GERARD , KNIGHT STEVEN DAVID , ADAMS NICHOLAS D , SCHMIDT STANLEY J
IPC分类号: A61K31/44 , C07D215/04
CPC分类号: C07D417/14
摘要: Invented is a method of inhibiting the activity/function of PI3 kinases using thiazolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiazolidinedione derivatives.
摘要翻译: 本发明是使用噻唑烷二酮衍生物抑制PI3激酶活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用噻唑烷二酮衍生物的移植排斥和肺损伤。
-
公开(公告)号:WO2002090337A1
公开(公告)日:2002-11-14
申请号:PCT/US2002/014412
申请日:2002-05-07
申请人: SMITHKLINE BEECHAM CORPORATION , DHANAK, Dashyant , GALLAGHER, Timothy, F. , KNIGHT, Steven, D. , SCHMIDT, Stanley, J.
IPC分类号: C07D239/46
CPC分类号: C07D239/60
摘要: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
摘要翻译: 本发明涉及磺酰胺,含有它们的药物组合物,以及它们作为尿素调节素II拮抗剂的用途。
-
公开(公告)号:WO2012064642A1
公开(公告)日:2012-05-18
申请号:PCT/US2011/059563
申请日:2011-11-07
申请人: GLAXOSMITHKLINE LLC , ADAMS, Nicholas, D. , CHAUDHARI, Amita, M. , KIESOW, Terence, John , PARRISH, Cynthia, Ann , REIF, Alexander, Joseph , RIDGERS, Lance, Howard , SCHMIDT, Stanley, J. , WIGGALL, Kenneth
发明人: ADAMS, Nicholas, D. , CHAUDHARI, Amita, M. , KIESOW, Terence, John , PARRISH, Cynthia, Ann , REIF, Alexander, Joseph , RIDGERS, Lance, Howard , SCHMIDT, Stanley, J. , WIGGALL, Kenneth
IPC分类号: A61K31/44
CPC分类号: C07D498/10 , A61K31/44 , A61K31/4709 , A61K31/499 , A61K31/5386 , A61K45/06 , C07D471/10 , C07D519/00
摘要: This invention relates to the use of spirocyclic piperidine derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
摘要翻译: 本发明涉及螺环哌啶衍生物用于调节,特别是抑制脂肪酸合成酶(FAS)活性或功能的用途。 合适地,本发明涉及螺环哌啶在治疗癌症中的用途。
-
公开(公告)号:WO2008157191A2
公开(公告)日:2008-12-24
申请号:PCT/US2008066619
申请日:2008-06-12
申请人: SMITHKLINE BEECHAM CORP , ADAMS NICHOLAS D , BURGESS JOELLE LORRAINE , DARCY MICHAEL GERARD , KNIGHT STEVEN DAVID , NEWLANDER KENNETH ALLEN , RIDGERS LANCE H , SCHMIDT STANLEY J
发明人: ADAMS NICHOLAS D , BURGESS JOELLE LORRAINE , DARCY MICHAEL GERARD , KNIGHT STEVEN DAVID , NEWLANDER KENNETH ALLEN , RIDGERS LANCE H , SCHMIDT STANLEY J
IPC分类号: A61K31/517 , A61K31/5377 , A61P9/00 , A61P25/00 , A61P35/00 , A61P35/02 , C07D401/14 , C07D413/14
CPC分类号: A61K31/5377 , A61K31/517 , C07D401/04 , C07D401/14 , C07D471/04
摘要: Invented is a method of inhibiting the activity/function of P13 kinases using quinazoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinazoline derivatives.
摘要翻译: 本发明是使用喹唑啉衍生物抑制P13激酶活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用喹唑啉衍生物的移植物排斥和肺损伤。
-
公开(公告)号:WO2008144463A1
公开(公告)日:2008-11-27
申请号:PCT/US2008/063819
申请日:2008-05-16
申请人: SMITHKLINE BEECHAM CORPORATION , ADAMS, Nicholas, D. , BURGESS, Joelle, Lorraine , DARCY, Michael, Gerard , DONATELLI, Carla, A. , KNIGHT, Steven, David , NEWLANDER, Kenneth, Allen , RIDGERS, Lance , SARPONG, Martha , SCHMIDT, Stanley, J.
发明人: ADAMS, Nicholas, D. , BURGESS, Joelle, Lorraine , DARCY, Michael, Gerard , DONATELLI, Carla, A. , KNIGHT, Steven, David , NEWLANDER, Kenneth, Allen , RIDGERS, Lance , SARPONG, Martha , SCHMIDT, Stanley, J.
IPC分类号: A61K31/47
CPC分类号: C07D498/04 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/5383 , A61K31/549 , A61K45/06 , C07D285/24 , C07D401/04 , C07D401/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
摘要: Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
摘要翻译: 本发明是使用喹啉衍生物抑制PB激酶的活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过给药喹啉衍生物的移植物排斥反应和肺损伤。
-
公开(公告)号:WO2002089785A1
公开(公告)日:2002-11-14
申请号:PCT/US2002/014407
申请日:2002-05-07
申请人: SMITHKLINE BEECHAM CORPORATION , DHANAK, Dashyant , GALLAGHER, Timothy, F. , KNIGHT, Steven, D. , SCHMIDT, Stanley, J.
IPC分类号: A61K31/18
CPC分类号: C07D409/04 , C07C311/14 , C07C311/29 , C07D333/34
摘要: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
-
-
-
-
-
-
-